Friedreich Ataxia-Pipeline Insights, 2015

◆상품코드 : DELVP501257
◆발행일 : 2015년판 (※최신판은 문의주세요)
◆페이지수 : Above 60
◆보고서 형식 : PDF / 영문
◆납품 방식 : Email (Three Days)
◆조사대상 지역 : Global
◆산업분야 : Pharmaceutical
◆발행회사(조사회사) : DelveInsight
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥141,250 -> 환산 ₩1,412,500견적의뢰/구매/질문FORM
Site Price¥282,500 -> 환산 ₩2,825,000견적의뢰/구매/질문FORM
Enterprise Price¥452,000 -> 환산 ₩4,520,000견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

SUMMARY
DelveInsight’s,“ Friedreich Ataxia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Friedreich Ataxia. This report provides information on the therapeutic development based on the Friedreich Ataxia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Friedreich Ataxia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Friedreich Ataxia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Friedreich Ataxia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


[조사보고서 목차]

Table of Contents
• Friedreich Ataxia Overview
• Friedreich Ataxia Pipeline Therapeutics
• Friedreich Ataxia Therapeutics under Development by Companies
• Friedreich Ataxia Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Friedreich Ataxia Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Friedreich Ataxia Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Friedreich Ataxia Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Friedreich Ataxia – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Friedreich Ataxia – Discontinued Products
• Friedreich Ataxia – Dormant Products
• Companies Involved in Therapeutics Development for Friedreich Ataxia
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Friedreich Ataxia, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Friedreich Ataxia Assessment by Monotherapy Products
• Friedreich Ataxia Assessment by Combination Products
• Friedreich Ataxia Assessment by Route of Administration
• Friedreich Ataxia Assessment by Stage and Route of Administration
• Friedreich Ataxia Assessment by Molecule Type
• Friedreich Ataxia Assessment by Stage and Molecule Type
• Friedreich Ataxia Therapeutics – Discontinued Products
• Friedreich Ataxia Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Friedreich Ataxia, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Friedreich Ataxia Assessment by Monotherapy Products
• Friedreich Ataxia Assessment by Combination Products
• Friedreich Ataxia Assessment by Route of Administration
• Friedreich Ataxia Assessment by Stage and Route of Administration
• Friedreich Ataxia Assessment by Molecule Type
• Friedreich Ataxia Assessment by Stage and Molecule Type


[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Friedreich Ataxia-Pipeline Insights, 2015]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆